FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Commercial · sales Widening supply of its approved imaging AI to university hospitals and teleradiology providers.

  • Supplied generative chest X-ray AI to a teleradiology provider. Source

Roles often seen at this stageData & AI · Sales & marketing · Regulatory affairs

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Deepnoid

A medical-imaging AI company supplying hospitals with generative AI that drafts chest X-ray reports and AI that assists brain-aneurysm diagnosis.

M4CXR

Marketed

Generative AI that drafts preliminary chest X-ray reports, supplied to university hospitals and a teleradiology provider.

Announced

Supplied its generative chest X-ray AI to a teleradiology provider for the first time.

Official role guide

Deepnoid careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 딥노이드, 영상의학 전문기관에 'M4CXR' 공급…판독시장 확대 ↗네이트 뉴스 · Published 2026-09-16 · Sources checked 2026-11-15 · Original unavailable
  2. Deepnoid expands state-funded program lineup to two products ↗Financial News · Published 2026-10-07 · Sources checked 2026-11-15 · Original unavailable